By Jonathan Serrie
Published October 23, 2012
Four weeks after the recall of tainted steroids amid a deadly fungal meningitis outbreak, it remains unclear how widespread the problem is.
The Food and Drug Administration
removed a list of clinics Monday that received products from the New England
Compounding Center, just hours after posting it on its website.
“FDA has found some technical problems
with the list and the data are incorrect,” a note on the FDA’s website
explained. “FDA is working to correct the list and will re-post when we
are sure it is accurate.”